Table 6.6c

Immunosuppression Use: Maintenance Between Discharge

and One Year Posttransplant, 1993 to 2002

Recipients with Pancreas Transplant Alone (PTA) Transplants

		Year of Transplant
		1993	1994	1995	1996	1997	1998	1999	2000	2001	2002
Transplants		54	40	41	53	79	88	137	135	165	177
Tx With Follow-up Immunosuppression Info		30	29	31	41	58	71	116	103	131	144
Corticosteroids	Category Usage	20.0%	48.3%	80.6%	97.6%	100.0%	100.0%	100.0%	98.1%	93.1%	90.3%
	Steroids	20.0%	48.3%	80.6%	97.6%	100.0%	100.0%	100.0%	98.1%	93.1%	90.3%
Cyclosporine	Category Usage	90.0%	48.3%	45.2%	48.8%	24.1%	18.3%	7.8%	7.8%	7.6%	8.3%
	Cyclosporin	90.0%	48.3%	22.6%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
	Sandimmmune	3.3%	3.4%	9.7%	9.8%	1.7%	0.0%	0.0%	1.9%	0.0%	0.0%
	Neoral	0.0%	0.0%	29.0%	46.3%	22.4%	18.3%	7.8%	4.9%	7.6%	6.3%
	Gengraf	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	1.0%	0.8%	1.4%
	Eon	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.7%
Tacrolimus	Category Usage	13.3%	69.0%	58.1%	73.2%	81.0%	91.5%	94.0%	95.1%	98.5%	95.1%
	FK506	13.3%	69.0%	58.1%	73.2%	81.0%	91.5%	94.0%	95.1%	98.5%	95.1%
Antimetabolites	Category Usage	86.7%	93.1%	96.8%	95.1%	91.4%	90.1%	91.4%	85.4%	77.1%	71.5%
	Azathioprine	86.7%	93.1%	51.6%	14.6%	12.1%	12.7%	2.6%	5.8%	2.3%	1.4%
	Mycophenolate mofetil	0.0%	3.4%	61.3%	90.2%	81.0%	84.5%	91.4%	82.5%	74.8%	70.8%
	Cytoxan	0.0%	0.0%	0.0%	2.4%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Other	Category Usage	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	17.2%	24.3%	15.3%	31.3%
	Rapamycin	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	17.2%	24.3%	15.3%	31.3%

Source: OPTN/SRTR Data as of May 3, 2004.

Individual drug percentages will not necessarily add up to the drug category percentages, as patients may

be prescribed more than one drug within the same category.